{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:52:42Z","timestamp":1791399162289,"version":"4.3.3"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR-103-085"],"award-info":[{"award-number":["DMR-103-085"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence","award":["MOHW103-TDU-B-212-113002"],"award-info":[{"award-number":["MOHW103-TDU-B-212-113002"]}]}],"content-domain":{"domain":["journalofpsychiatricresearch.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jpsychires.2015.10.007","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T09:31:08Z","timestamp":1445765468000},"page":"58-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["Decreased mRNA expression for the two subunits of system xc\u2212, SLC3A2 and SLC7A11, in WBC in patients with schizophrenia: Evidence in support of the hypo-glutamatergic hypothesis of schizophrenia"],"prefix":"10.1016","volume":"72","author":[{"given":"Chieh-Hsin","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Pei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Hsien","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien-Yuan","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2015.10.007_bib1","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.jpsychires.2015.10.007_bib2","series-title":"Structured Clinical Interview for DSM-IV","author":"American Psychiatric Association","year":"1994"},{"issue":"7","key":"10.1016\/j.jpsychires.2015.10.007_bib3","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/sj.npp.1301532","article-title":"Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine","volume":"33","author":"Baker","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.jpsychires.2015.10.007_bib4","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nn1069","article-title":"Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse","volume":"6","author":"Baker","year":"2003","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.jpsychires.2015.10.007_bib5","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/S0021-9258(17)35926-4","article-title":"Exchange of cystine and glutamate across plasma membrane of human fibroblasts","volume":"261","author":"Bannai","year":"1986","journal-title":"J.\u00a0Biol. Chem."},{"issue":"5984","key":"10.1016\/j.jpsychires.2015.10.007_bib6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/311308b0","article-title":"Amino acid transport systems","volume":"311","author":"Bannai","year":"1984","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jpsychires.2015.10.007_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1476-5381.2011.01480.x","article-title":"System xc(-) cystine\/glutamate antiporter: an update on molecular pharmacology and roles within the CNS","volume":"165","author":"Bridges","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.jpsychires.2015.10.007_bib8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1369\/jhc.5A6840.2006","article-title":"Distribution of the cystine\/glutamate antiporter system xc- in the brain, kidney, and duodenum","volume":"54","author":"Burdo","year":"2006","journal-title":"J.\u00a0Histochem. Cytochem. Off. J. Histochem. Soc."},{"issue":"4","key":"10.1016\/j.jpsychires.2015.10.007_bib9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1515\/BC.2003.059","article-title":"Glutathione pathways in the brain","volume":"384","author":"Dringen","year":"2003","journal-title":"Biol. Chem."},{"key":"10.1016\/j.jpsychires.2015.10.007_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jpba.2015.03.024","article-title":"d-Aspartate: an endogenous NMDA receptor agonist enriched in the developing brain with potential involvement in schizophrenia","volume":"116","author":"Errico","year":"2015","journal-title":"J.\u00a0Pharm. Biomed. analysis"},{"issue":"6","key":"10.1016\/j.jpsychires.2015.10.007_bib11","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/archpsyc.60.6.572","article-title":"Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia","volume":"60","author":"Hashimoto","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"issue":"102","key":"10.1016\/j.jpsychires.2015.10.007_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002804","article-title":"Translating glutamate: from pathophysiology to treatment","volume":"3","author":"Javitt","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.jpsychires.2015.10.007_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.nut.2010.01.014","article-title":"Dietary sulfur amino acid effects on fasting plasma cysteine\/cystine redox potential in humans","volume":"27","author":"Jones","year":"2011","journal-title":"Nutrition"},{"issue":"2","key":"10.1016\/j.jpsychires.2015.10.007_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0005-2736(01)00338-8","article-title":"Human cystine\/glutamate transporter: cDNA cloning and upregulation by oxidative stress in glioma cells","volume":"1512","author":"Kim","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.jpsychires.2015.10.007_bib15","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.biopsych.2008.10.040","article-title":"The role of cystine-glutamate exchange in nicotine dependence in rats and humans","volume":"65","author":"Knackstedt","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.jpsychires.2015.10.007_bib16","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.biopsych.2008.06.011","article-title":"Capitalizing on extrasynaptic glutamate neurotransmission to treat antipsychotic-resistant symptoms in schizophrenia","volume":"64","author":"Krystal","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.jpsychires.2015.10.007_bib17","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/jamapsychiatry.2013.2159","article-title":"Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor","volume":"70","author":"Lane","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.10.007_bib18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jpsychires.2014.12.007","article-title":"Behavioral and cognitive effects of the N-methyl-D-aspartate receptor co-agonist D-serine in healthy humans: initial findings","volume":"61","author":"Levin","year":"2015","journal-title":"J.\u00a0Psychiatric Res."},{"issue":"5","key":"10.1016\/j.jpsychires.2015.10.007_bib19","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1089\/ars.2011.4391","article-title":"The cystine\/glutamate antiporter system xc\u2212 in health and disease: from molecular mechanisms to novel therapeutic opportunities","volume":"18","author":"Lewerenz","year":"2013","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.jpsychires.2015.10.007_bib20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00726-011-0862-x","article-title":"Regulation of xCT expression and system x (c) (-) function in neuronal cells","volume":"42","author":"Lewerenz","year":"2012","journal-title":"Amino Acids"},{"issue":"6","key":"10.1016\/j.jpsychires.2015.10.007_bib21","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/mp.2013.80","article-title":"Distinctively higher plasma G72 protein levels in patients with schizophrenia than in healthy individuals","volume":"19","author":"Lin","year":"2014","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2015.10.007_bib22","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.pbb.2011.03.023","article-title":"Glutamate signaling in the pathophysiology and therapy of schizophrenia","volume":"100","author":"Lin","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jpsychires.2015.10.007_bib23","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1196\/annals.1297.059","article-title":"Glutathione metabolism during aging and in Alzheimer disease","volume":"1019","author":"Liu","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.jpsychires.2015.10.007_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"16","key":"10.1016\/j.jpsychires.2015.10.007_bib25","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/WNR.0b013e328312181c","article-title":"Time-dependent changes in striatal xCT protein expression in hemi-Parkinson rats","volume":"19","author":"Massie","year":"2008","journal-title":"Neuroreport"},{"issue":"5258","key":"10.1016\/j.jpsychires.2015.10.007_bib26","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/227611a0","article-title":"Monosodium glutamate and the Chinese restaurant syndrome","volume":"227","author":"Morselli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.jpsychires.2015.10.007_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.biocel.2015.08.004","article-title":"LAT1 is the transport competent unit of the LAT1\/CD98 heterodimeric amino acid transporter","volume":"67","author":"Napolitano","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.jpsychires.2015.10.007_bib28","doi-asserted-by":"crossref","first-page":"C1047","DOI":"10.1152\/ajpcell.00416.2010","article-title":"4F2hc stabilizes GLUT1 protein and increases glucose transport activity. American journal of physiology","volume":"300","author":"Ohno","year":"2011","journal-title":"Cell Physiol."},{"issue":"1","key":"10.1016\/j.jpsychires.2015.10.007_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pnpbp.2010.08.027","article-title":"Significance of NMDA receptor-related glutamatergic amino acid levels in peripheral blood of patients with schizophrenia","volume":"35","author":"Ohnuma","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2015.10.007_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1742-2094-8-63","article-title":"Increased expression of cystine\/glutamate antiporter in multiple sclerosis","volume":"8","author":"Pampliega","year":"2011","journal-title":"J.\u00a0Neuroinflammation"},{"issue":"12","key":"10.1016\/j.jpsychires.2015.10.007_bib31","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1523\/JNEUROSCI.5186-05.2006","article-title":"System Xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40","volume":"26","author":"Qin","year":"2006","journal-title":"J.\u00a0Neurosci. Off. J. Soc. Neurosci."},{"issue":"17","key":"10.1016\/j.jpsychires.2015.10.007_bib32","doi-asserted-by":"crossref","first-page":"11455","DOI":"10.1074\/jbc.274.17.11455","article-title":"Cloning and expression of a plasma membrane cystine\/glutamate exchange transporter composed of two distinct proteins","volume":"274","author":"Sato","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"issue":"6\u20137","key":"10.1016\/j.jpsychires.2015.10.007_bib33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuint.2007.03.012","article-title":"The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention","volume":"51","author":"Sheldon","year":"2007","journal-title":"Neurochem. Int."},{"issue":"41","key":"10.1016\/j.jpsychires.2015.10.007_bib34","doi-asserted-by":"crossref","first-page":"10514","DOI":"10.1523\/JNEUROSCI.3178-06.2006","article-title":"Cystine\/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation","volume":"26","author":"Shih","year":"2006","journal-title":"J.\u00a0Neurosci. Official J. Soc. Neurosci."},{"issue":"3","key":"10.1016\/j.jpsychires.2015.10.007_bib35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ajmg.b.30272","article-title":"Evaluating the comparability of gene expression in blood and brain","volume":"141B","author":"Sullivan","year":"2006","journal-title":"Am. J. Med. Genet. Part B, Neuropsychiatric Genet."},{"issue":"3","key":"10.1016\/j.jpsychires.2015.10.007_bib36","first-page":"774","article-title":"Induction of xCT gene expression and L-cystine transport activity by diethyl maleate at the inner blood-retinal barrier","volume":"43","author":"Tomi","year":"2002","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jpsychires.2015.10.007_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2009.02.040","article-title":"Levetiracetam enhances endogenous antioxidant in the hippocampus of rats: in\u00a0vivo evaluation by brain microdialysis combined with ESR spectroscopy","volume":"1266","author":"Ueda","year":"2009","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.jpsychires.2015.10.007_bib38","doi-asserted-by":"crossref","first-page":"e60099","DOI":"10.1371\/journal.pone.0060099","article-title":"The DAO gene is associated with schizophrenia and interacts with other genes in the Taiwan Han Chinese population","volume":"8","author":"Yang","year":"2013","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.jpsychires.2015.10.007_bib39","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1586\/17512433.2015.1040393","article-title":"Glutamatergic agents for schizophrenia: current evidence and perspectives","volume":"8","author":"Zink","year":"2015","journal-title":"Expert Rev. Clin. Pharmacol."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395615002964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395615002964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:29:47Z","timestamp":1653352187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395615002964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":39,"alternative-id":["S0022395615002964"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2015.10.007","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased mRNA expression for the two subunits of system xc\u2212, SLC3A2 and SLC7A11, in WBC in patients with schizophrenia: Evidence in support of the hypo-glutamatergic hypothesis of schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2015.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}